Proposed issue of securities

Announcement Summary

For personal use only

Entity name

MEDIBIO LIMITED

Announcement Type

New announcement

Date of this announcement

15/12/2021

The Proposed issue is:

A standard pro rata issue (including non-renounceable or renounceable)

A placement or other type of issue

Total number of +securities proposed to be issued for a standard pro rata issue (including non-renounceable or renounceable)

Maximum Number of

ASX +security code

+Security description

+securities to be issued

MEB

ORDINARY FULLY PAID

687,017,041

MEBOC

OPTION EXPIRING 28-FEB-2024

343,508,521

Ex date

17/1/2022

+Record date

18/1/2022

Offer closing date

11/2/2022

Issue date

16/2/2022

Total number of +securities proposed to be issued for a placement or other type of issue

Maximum Number of

ASX +security code

+Security description

+securities to be issued

MEB

ORDINARY FULLY PAID

450,049,250

MEBOC

OPTION EXPIRING 28-FEB-2024

225,024,625

Proposed issue of securities

1 / 13

Proposed issue of securities

Proposed +issue date

20/12/2021

Refer to next page for full details of the announcement

For personal use only

Proposed issue of securities

2 / 13

Proposed issue of securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of +Entity

MEDIBIO LIMITED

We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).

1.2

Registered Number Type

Registration Number

ABN

58008130336

1.3

ASX issuer code

MEB

  1. The announcement is New announcement
  2. Date of this announcement

15/12/2021

1.6 The Proposed issue is:

A standard +pro rata issue (non-renounceable or renounceable)

A placement or other type of issue

1.6a The proposed standard +pro rata issue is: + Non-renounceable

Proposed issue of securities

3 / 13

Proposed issue of securities

Part 3 - Details of proposed entitlement offer issue

only

Part 3A - Conditions

3A.1 Do any external approvals need to be obtained or other conditions satisfied before the entitlement offer can

proceed on an unconditional basis?

use

No

Part 3B - Offer details

Class or classes of +securities that will participate in the proposed issue and class or classes of +securities

personal

proposed to be issued

ASX +security code and description

MEB : ORDINARY FULLY PAID

Is the proposed security a 'New

Will the proposed issue of this

If the entity has quoted company

class' (+securities in a class that is

+security include an offer of

options, do the terms entitle option

not yet quoted or recorded by ASX)

attaching +securities?

holders to participate on exercise?

or an 'Existing class' (additional

Yes

No

securities in a class that is already

quoted or recorded by ASX)?

Existing class

D tails of +securities proposed to be issued

ASX +security code and description

MEB : ORDINARY FULLY PAID

For

ISIN Code (if Issuer is a foreign company and +securities are non CDIs)

ISIN Code for the entitlement or right to participate in a non-renounceable

issue (if Issuer is foreign company and +securities are non CDIs)

Offer ratio (ratio to existing holdings at which the proposed +securities will be issued)

The quantity of additional +securities to be issued

For a given quantity of +securities held

1

3

Proposed issue of securities

4 / 13

Proposed issue of securities

What will be done with fractional entitlements?

Maximum number of +securities proposed to be issued (subject to rounding)

only

Fractions rounded up to the next

687,017,041

whole number

Offer price details for retail security holders

In what currency will the offer be

What is the offer price per +security

made?

for the retail offer?

AUD - Australian Dollar

AUD 0.00500

use

Oversubscription & Scale back details

personal

Will individual +security holders be permitted to apply for more than their

entitlement (i.e. to over-subscribe)?

Yes

Describe the limits on over-subscription

Eligible shareholders who apply for their Entitlement in full may apply for additional Shares under the Shortfall. If eligible

shareholders subscribe for more Shares than are available under the Shortfall, the Company will apply a scale-back

procedure to ensure a fair allocation of the shortfall.

Will a scale back be applied if the offer is over-subscribed?

Yes

Describe the scale back arrangements

In the event of a scale back, Eligible Shareholders' applications will be scaled back using a consistent percentage across

all applications.

Will these +securities rank equally in all respects from their issue date with

the existing issued +securities in that class?

For

Yes

Attaching +Security

Is the proposed attaching security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional +securities in a class that is already quoted or recorded by ASX)?

Existing class

Attaching +Security - Existing class (additional +securities in a class that is already quoted or recorded by ASX)

Proposed issue of securities

5 / 13

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Medibio Limited published this content on 14 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 December 2021 23:48:07 UTC.